Morris D L, Ubhi C S, Robertson C S, Brammer K W
Rev Infect Dis. 1986 Nov-Dec;8 Suppl 5:S589-92. doi: 10.1093/clinids/8.supplement_5.s589.
The biliary pharmacokinetics of sulbactam and ampicillin was investigated in 19 patients with normal liver function who were undergoing surgery of the biliary tract. The combination of sulbactam (0.5 g) plus ampicillin (1 g) was given intravenously to five patients with T-tube drainage of the common bile duct. Mean peak concentrations of sulbactam (19.4 micrograms/ml) and ampicillin (471 micrograms/ml) in the bile occurred 0.5-1 hr after administration. Biliary excretion was estimated to account for approximately 0.24% of the sulbactam dose and 2.8% of the ampicillin dose. Fourteen other patients received the same dose of sulbactam/ampicillin immediately before elective cholecystectomy. Respective mean concentrations of sulbactam and ampicillin at the time of gallbladder removal were 4.3 micrograms/ml and 15.9 micrograms/ml in gallbladder bile and 6.3 micrograms/g and 7.7 micrograms/g in gallbladder wall tissue. These results, together with the antibacterial spectrum and potency of the combination, suggest that sulbactam/ampicillin is suitable for prophylactic use in biliary tract surgery.
对19例肝功能正常且正在接受胆道手术的患者进行了舒巴坦和氨苄西林的胆汁药代动力学研究。对5例胆总管T管引流患者静脉注射舒巴坦(0.5g)加氨苄西林(1g)的联合制剂。给药后0.5 - 1小时,胆汁中舒巴坦的平均峰值浓度为19.4微克/毫升,氨苄西林的平均峰值浓度为471微克/毫升。据估计,胆汁排泄量约占舒巴坦剂量的0.24%和氨苄西林剂量的2.8%。另外14例患者在择期胆囊切除术即将开始前接受了相同剂量的舒巴坦/氨苄西林。在切除胆囊时,胆囊胆汁中舒巴坦和氨苄西林的各自平均浓度分别为4.3微克/毫升和15.9微克/毫升,胆囊壁组织中分别为6.3微克/克和7.7微克/克。这些结果,连同该联合制剂的抗菌谱和效力,表明舒巴坦/氨苄西林适用于胆道手术的预防性使用。